A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2013
12/04/2013	CN103417542A Oral solid preparation for treatment of leukemia and application thereof
12/04/2013	CN103417536A Applications of harmol in preparation of antitumor drugs
12/04/2013	CN103417533A Application of TPCA-1 as STAT3 signal inhibitor in preparation of antitumor drug
12/04/2013	CN103417532A Sesquiterpene lactone compound and uses of derivative thereof in preparation of drugs
12/04/2013	CN103417530A Method for applying artemisinin derivative and lipidosome of artemisinin derivative to preparation of sound sensitive agent
12/04/2013	CN103417528A New application of isojacareubin
12/04/2013	CN103417527A Medical uses of methyl (E)-3-[2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]-prop-2-enoate
12/04/2013	CN103417521A Application of 3,4-Dihydroxyphenylacetic acid in preparing antitumor drug
12/04/2013	CN103417518A Application of oxidized resveratrol for preparing tumor treatment drugs
12/04/2013	CN103417500A Cobamamide freeze-drying agent and preparation method thereof
12/04/2013	CN103417482A TNP-470 (O-(chloroacetyl-carbamoyl)fumagillol) loaded slow-release nanoparticle and preparation method and application thereof
12/04/2013	CN103417480A Novel polypeptide modified tumor targeted liposome of targeted integrin receptor
12/04/2013	CN103417479A Ginsenoside Rg3 liposome and preparation method thereof
12/04/2013	CN103417468A 一种依托泊苷植入剂 One kind of etoposide implants
12/04/2013	CN103417467A Dexamethasone implant
12/04/2013	CN103417191A Multifunctional Raman probe with detection, hyperthermia and chemotherapy properties
12/04/2013	CN103416312A Plants as functional siRNA vehicles and preparation methods and uses thereof
12/04/2013	CN103416311A Plants as functional microRNA vehicles and preparation methods and uses thereof
12/04/2013	CN102772745B Chinese medicinal preparation for treating cancer and preparation method thereof
12/04/2013	CN102688472B Medicinal composition for preventing or relieving yang deficiency syndrome of tumor patient
12/04/2013	CN102671111B Chinese medicinal composition for treating malignant soft tissue neoplasm
12/04/2013	CN102670526B 奥沙利铂冻干粉针剂及其制备方法 Oxaliplatin freeze-dried powder and its preparation method
12/04/2013	CN102631521B Method for extracting dioscin by utilizing two-aqueous-phase system
12/04/2013	CN102614471B Traditional Chinese medicine for treating breast carcinoma
12/04/2013	CN102600089B Medicine composition containing raltitrexed and preparation method of medicine composition
12/04/2013	CN102579353B Pegylated liposome of folate-targeted anticancer drug and preparation method
12/04/2013	CN102558351B Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof
12/04/2013	CN102424818B Caspase-1-ES cell line induced by mifepristone
12/04/2013	CN102352368B ING4 and OSM double-gene co-expression vector and application thereof
12/04/2013	CN102304086B Heterocyclic inhibitors of MEK and methods of use thereof
12/04/2013	CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones
12/04/2013	CN102292081B Pharmaceutical association lipoic acid and hydroxycitric acid as active ingredients
12/04/2013	CN102242079B Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
12/04/2013	CN102134275B 表皮生长因子受体变异体 Epidermal growth factor receptor variant
12/04/2013	CN102115472B 3-(2-pyrromethene)azaindoline-2-one derivatives and preparation method and application thereof
12/04/2013	CN102058642B Ginseng saponin extract and preparation method thereof
12/04/2013	CN101926993B Adjuvant systems and vaccines
12/04/2013	CN101827811B Histone deacetylase inhibitor, preparation and use thereof
12/04/2013	CN101613264B Annulenone compounds and application thereof in preparing anti-tumor medicaments
12/04/2013	CN101443340B Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use
12/04/2013	CN101137673B Cripto结合分子 Cripto binding molecules
12/03/2013	US8598324 Anti-pathogen treatments
12/03/2013	US8598318 Modified human thymic stromal lymphopoietin
12/03/2013	US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases
12/03/2013	US8598215 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
12/03/2013	US8598190 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
12/03/2013	US8598184 Protein kinase inhibitors
12/03/2013	US8598167 Substituted 6,5-fused bicyclic heteroaryl compounds
12/03/2013	US8598126 Peptides for inhibiting the HPV-E6 oncoprotein
12/03/2013	US8597656 Process for the production of immunogenic compositions
12/03/2013	US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod
12/03/2013	CA2684165C Oligonucleotide-prolyethylene glycol compound
12/03/2013	CA2621830C 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
12/03/2013	CA2599411C Enzyme inhibitors
12/03/2013	CA2583499C Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
12/03/2013	CA2570780C Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
12/03/2013	CA2530302C Novel aminobenzophenone compounds
12/03/2013	CA2504270C Peptide fragments of the harp factor inhibiting angiogenesis
12/03/2013	CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule
12/03/2013	CA2397207C Novel stra6 polypeptides
12/03/2013	CA2240834C Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
11/2013
11/30/2013	CA2790763A1 Aptamer bioconjugate drug delivery device
11/28/2013	WO2013177481A1 Benzodiazepines and conjugates thereof
11/28/2013	WO2013177418A1 Methods of regulating cannabinoid receptor activity-related disorders and diseases
11/28/2013	WO2013177415A1 Lipid nanoparticle compositions for antisense oligonucleotides delivery
11/28/2013	WO2013177386A1 Biomarkers for predicting response to tweak receptor (tweakr) agonist therapy
11/28/2013	WO2013177168A1 Pyrimidine compounds for the treatment of cancer
11/28/2013	WO2013177157A1 Humanized anti-il-20 antibody and uses thereof
11/28/2013	WO2013177102A2 Treatment of cancer by manipulating the immune system
11/28/2013	WO2013177096A1 A method for the treatment of cancer
11/28/2013	WO2013177053A1 Pyrimidino [1, 2 -c] quinazolinone derivatives as tyrosine kinases inhibitors
11/28/2013	WO2013176623A1 Inhibitors for the treatment of cancer
11/28/2013	WO2013176563A1 Biologically active peptide complexes
11/28/2013	WO2013176293A1 Novel bicyclic thiazole compounds
11/28/2013	WO2013176197A1 Method for producing antigen-specific t cells
11/28/2013	WO2013175483A1 Process for preparing crystalline sorafenib tosylate
11/28/2013	WO2013175474A2 Selective inhibitors of undifferentiated cells
11/28/2013	WO2013175417A1 Pyrrolopyrrolidinone compounds
11/28/2013	WO2013175415A1 Substituted pyrimidine compounds and uses thereof
11/28/2013	WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors
11/28/2013	WO2013175009A1 Ulipristal acetate for prevention and treatment of breast tumors
11/28/2013	WO2013174997A1 Methods and pharmaceutical compositions for the treatment of refractory haematological malignancies
11/28/2013	WO2013174947A1 Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
11/28/2013	WO2013174876A1 Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
11/28/2013	WO2013174863A1 Chondroitin for use in medicine
11/28/2013	WO2013174744A1 Thienopyrimidines
11/28/2013	WO2013174743A1 Substituted pyrrolopyrimidines
11/28/2013	WO2013174735A1 Substituted benzothienopyrimidines
11/28/2013	WO2013174261A1 Method for preparing erlotinib hydrochloride crystalline form a
11/28/2013	WO2013174207A1 Protein tyrosine phosphatase inhibitor, preparation method and uses thereof
11/28/2013	WO2013173971A1 Use of fructus ligustri lucidi in the manufacture of a medicament for the prevention or treatment of a condition linked to weak bones in a young subject
11/28/2013	WO2013131089A3 Potent anticancer activity via dual compound activation
11/28/2013	WO2012156877A8 Treating skin exposed to uv radiation with quetiapine or analogs thereof
11/28/2013	WO2012125828A8 Methods of treating breast cancer with anthracycline therapy
11/28/2013	WO2012068531A3 Novel compositions and uses of anti-hypertension agents for cancer therapy
11/28/2013	US20130317013 Ep4 receptor agonist, compositions and methods thereof
11/28/2013	US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/28/2013	US20130315949 Molecular Antigen Array
11/28/2013	US20130315893 Humanized anti-il-20 antibody and uses thereof
11/28/2013	US20130315828 Kit and method of use of targeting peptide for diagnosis and therapy of cancer

1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 2211